-
Chronic hypertension and adverse pregnancy outcomes: a cohort study.
Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:228-235. pdf -
Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:203-9. pdf -
Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valino N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:194-202. pdf -
Maternal age and adverse pregnancy outcomes: a cohort study.
Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;42:634-43. pdf -
Maternal racial origin and adverse pregnancy outcome: a cohort study.
Khalil A, Rezende J, Akolekar R, Syngelaki A, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;41:278-85. -
Maternal serum placental growth hormone at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
J Matern Fetal Neonatal Med 2012;25:1796-9. -
Maternal serum insulin-like growth factor (IGF-I) and binding proteins IGFBP-1 and IGFBP-3 at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates.
Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH.
Eur J Obstet Gynecol Reprod Biol 2012;161:30-3. -
First-trimester maternal serum vitamin D and mode of delivery.
Savvidou MD, Makgoba M, Castro PT, Akolekar R, Nicolaides KH.
Br J Nutr 2012;24:1-4. -
First trimester maternal serum free ß-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
Savvidou M, Syngelaki A, Muhaisen M, Emelyanenko E, Nicolaides KH.
BJOG 2012;119:410-6. -
Yolk sac diameter in early pregnancy in maternal diabetes mellitus.
Papaioannou GI, Syngelaki A, Maiz N, Ross JA, Nicolaides KH.
Gynecol Obstet Invest 2012;73:16-20. -
Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies.
Nanda S, Poon LC, Muhaisen M, Acosta IC, Nicolaides KH.
Metabolism 2012;61:699-705. -
Comparison of two different sites of measurement for transabdominal uterine artery Doppler velocimetry at 11-13 weeks.
Lefebvre J, Demers S, Bujold E, Nicolaides KH, Girard M, Brassard N, Audibert F.
Ultrasound Obstet Gynecol 2012;40:288-92. -
Maternal hemodynamics at 11-13 weeks of gestation in pregnancies delivering small for gestational age neonates.
Khalil A, Sodre D, Syngelaki A, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2012;32:231-8. -
Maternal hemodynamics at 11-13 weeks' gestation in gestational diabetes mellitus.
Khalil A, Garcia-Mandujano R, Chiriac R, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2012;31:216-20. -
Maternal serum vitamin D at 11-13 weeks in pregnancies delivering small for gestational age neonates.
Ertl R, Yu CK, Samaha R, Akolekar R, Nicolaides KH.
Fetal Diagn Ther 2012;31:103-8. -
Body Mass Index at 11-13 Weeks' Gestation and Pregnancy Complications.
Syngelaki A, Bredaki FE, Vaikousi E, Maiz N, Nicolaides KH.
Fetal Diagn Ther 2011;30:250-65. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Effect of delivery on fetal erythropoietin and blood gases in pregnancies with maternal diabetes mellitus.
Salvesen DR, Brudenell MJ, Nicolaides KH.
Fetal Diagn Ther 1995;10:141-6.